SDZ-CO-611 - A HIGHLY POTENT GLYCATED ANALOG OF SOMATOSTATIN WITH IMPROVED ORAL ACTIVITY

被引:60
作者
ALBERT, R
MARBACH, P
BAUER, W
BRINER, U
FRICKER, G
BRUNS, C
PLESS, J
机构
[1] Sandoz Pharma Ltd., Preclinical Research Department
关键词
D O I
10.1016/0024-3205(93)90703-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To obtain orally active octreotide (Sandostatin(R), SMS 201-995) analogs a new class of glycated somatostatin derivatives were synthesized by the Amadori reaction (Maillard reaction). The synthesis, chemical and biological characterization of a series of new compounds is described. These oligopeptides bind with high affinity to somatostatin receptors and retain full biological activity. Whereas generally polypeptide hormones are almost completely inactive after oral administration, we report here for the first time that these analogs show remarkably high activity by the oral route. Thus for example SDZ CO 611, the D(+)-maltose Amadori derivative of octreotide, has about 10 times higher oral effect bioavailability than octreotide while maintaining the selectivity, metabolic stability and long duration of action of the parent compound.
引用
收藏
页码:517 / 525
页数:9
相关论文
共 19 条
[1]  
BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X
[2]  
Del Pozo E, 1977, Clin Endocrinol (Oxf), V6 Suppl, p47S
[3]  
DELEAN A, 1991, THESIS DUKE U NC US
[4]   ENDOCRINE PROFILE OF A LONG-ACTING SOMATOSTATIN DERIVATIVE SMS-201-995 - STUDY IN NORMAL VOLUNTEERS FOLLOWING SUBCUTANEOUS ADMINISTRATION [J].
DELPOZO, E ;
NEUFELD, M ;
SCHLUTER, K ;
TORTOSA, F ;
CLARENBACH, P ;
BIEDER, E ;
WENDEL, L ;
NUESCH, E ;
MARBACH, P ;
CRAMER, H ;
KERP, L .
ACTA ENDOCRINOLOGICA, 1986, 111 (04) :433-439
[5]   INTESTINAL-ABSORPTION OF THE OCTAPEPTIDE SMS-201-995 VISUALIZED BY FLUORESCENCE DERIVATIZATION [J].
FRICKER, G ;
BRUNS, C ;
MUNZER, J ;
BRINER, U ;
ALBERT, R ;
KISSEL, T ;
VONDERSCHER, J .
GASTROENTEROLOGY, 1991, 100 (06) :1544-1552
[6]  
FUSSL HS, 1987, CLIN SCI, V72, P255
[8]  
LAMBERTS SWJ, 1988, ENDOCR REV, V9, P427
[9]  
LEMAIRE M, 1989, DRUG METAB DISPOS, V17, P699
[10]  
MARBACH P, 1985, ADV EXP MED BIOL, V188, P339